These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8138682)

  • 1. [Phase II study of edobacomab (E5) in the treatment of gram-negative sepsis].
    Kobayashi H; Kawai S; Sakayori S; Kaneko M; Ito Y; Ujike Y; Kobayashi K; Imaizumi H; Hoshi S; Endo S
    Kansenshogaku Zasshi; 1994 Jan; 68(1):81-115. PubMed ID: 8138682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phase I study of edobacomab (E5) in patients with gram-negative sepsis].
    Kobayashi H; Kawai S; Sakayori S; Endo S; Hoshi S; Inada K; Yoshida M
    Kansenshogaku Zasshi; 1994 Jan; 68(1):59-80. PubMed ID: 8138680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.
    Barriere SL; Guglielmo BJ
    Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group.
    Bone RC; Balk RA; Fein AM; Perl TM; Wenzel RP; Reines HD; Quenzer RW; Iberti TJ; Macintyre N; Schein RM
    Crit Care Med; 1995 Jun; 23(6):994-1006. PubMed ID: 7774238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
    Gorelick KJ; Chmel H
    Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, gram-negative sepsis.
    Greenberg RN; Wilson KM; Kunz AY; Wedel NI; Gorelick KJ
    Crit Care Med; 1992 Jun; 20(6):730-5. PubMed ID: 1597023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.
    Greenman RL; Schein RM; Martin MA; Wenzel RP; MacIntyre NR; Emmanuel G; Chmel H; Kohler RB; McCarthy M; Plouffe J
    JAMA; 1991 Aug; 266(8):1097-102. PubMed ID: 1865542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E5 monoclonal immunoglobulin M antibody for the treatment of gram-negative sepsis.
    Olsen KM; Campbell GD
    DICP; 1991; 25(7-8):784-90. PubMed ID: 1949940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide.
    Fink MP
    Crit Care Med; 1993 Feb; 21(2 Suppl):S32-9. PubMed ID: 8428494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind phase II study of anti-endotoxin antibody (E5) as adjuvant therapy in humans with serious gram-negative infections.
    Greenberg RN; Wilson KM; Kunz AY; Wedel NI; Gorelick KJ
    Prog Clin Biol Res; 1991; 367():179-86. PubMed ID: 1924426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators.
    Angus DC; Birmingham MC; Balk RA; Scannon PJ; Collins D; Kruse JA; Graham DR; Dedhia HV; Homann S; MacIntyre N
    JAMA; 2000 Apr; 283(13):1723-30. PubMed ID: 10755499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins.
    Behre G; Schedel I; Nentwig B; Wörmann B; Essink M; Hiddemann W
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2139-46. PubMed ID: 1444293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to endotoxin in the treatment of gram-negative sepsis.
    van Deventer S
    JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765
    [No Abstract]   [Full Text] [Related]  

  • 15. Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis.
    Reinhart K; Meier-Hellmann A; Beale R; Forst H; Boehm D; Willatts S; Rothe KF; Adolph M; Hoffmann JE; Boehme M; Bredle DL;
    Crit Care Med; 2004 Aug; 32(8):1662-8. PubMed ID: 15286541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to endotoxin in the management of sepsis.
    Fang KC
    West J Med; 1993 Apr; 158(4):393-9. PubMed ID: 8317126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels.
    Wortel CH; von der Möhlen MA; van Deventer SJ; Sprung CL; Jastremski M; Lubbers MJ; Smith CR; Allen IE; ten Cate JW
    J Infect Dis; 1992 Dec; 166(6):1367-74. PubMed ID: 1431255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of immunomodulator therapy in sepsis.
    Caplan ES
    Am J Surg; 1993 Feb; 165(2A Suppl):20S-25S. PubMed ID: 8438996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effect of mouse antiendotoxin monoclonal antibody (E5) on hypotension induced by endotoxin and TNF-alpha].
    Inada K; Endo S; Yamashita H; Suzuki M; Yoshida H; Yoshida M
    Kansenshogaku Zasshi; 1993 Nov; 67(11):1108-14. PubMed ID: 8270802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin activity level and septic shock: a possible role for specific anti-endotoxin therapy?
    Monti G; Bottiroli M; Pizzilli G; Minnini M; Terzi V; Vecchi I; Gesu G; Brioschi P; Vesconi S; Casella G
    Contrib Nephrol; 2010; 167():102-110. PubMed ID: 20519904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.